Table 1.
Demographics and baseline characteristics patients.
| Characteristics | All patients (N=20) |
|---|---|
| Age, years | 56 (41 to 70) |
| Sex | |
| Male | 18 (90.0) |
| Female | 2 (10.0) |
| Bodyweight | |
| <60 kg | 12 (60.0) |
| ≥60 kg | 8 (40.0) |
| ECOG PS | |
| 0 | 6 (30.0) |
| 1 | 14 (70.0) |
| Child-Pugh classification | |
| A | 19 (95.0) |
| B7 | 1 (5.0) |
| BCLC stage | |
| B | 5 (25.0) |
| C | 15 (75.0) |
| Infection | |
| HBVa | 20 (100.0) |
| HCV | 0 (0.0) |
| AFP | |
| >400 ng/mL | 7 (35.0) |
| ≤400 ng/mL | 13 (65.0) |
| LDH | |
| >271,UL | 3 (15.0) |
| ≤271,UL | 17 (85.0) |
| Alcohol consumption | |
| Yes | 6 (30.0) |
| No | 14 (70.0) |
| Macrovascular invasion | |
| Yes | 4 (20.0) |
| No | 16 (80.0) |
| Extrahepatic spread | |
| Yes | 14 (70.0) |
| No | 6 (30.0) |
| No. of involved disease sites per patient | |
| 1 | 6 (30.0) |
| 2 | 9 (45.0) |
| 3 or more | 5 (25.0) |
| Previous local regional therapy | |
| Surgery | 11 (55.0) |
| TACE | 8 (40.0) |
| Local ablation Other |
2 (10.0) |
AFP, alpha-fetoprotein; ECOG, Eastern Cooperative Oncology; BCLC, Barcelona Clinic Liver Cancer; HBV, Hepatitis B virus; HCV, Hepatitis C virus; TACE, transarterial chemoembolization.
Data are median (range) or n(%).
a
HBV infection is defined as HBsAg+ and HBV DNA <2, 000 IU/mL.